ScripHuntington’s disease (HD) has been a notoriously difficult field for drug development but enthusiasm is growing, not least at Skyhawk Therapeutics which has initiated a Phase II/III trial on a potenti
ScripTrump Policies Draw Warnings From BIO Leadership US President Donald Trump was never directly called out by name, but BIO leadership discussed the risks posed by his policies on June 17 during the sec
ScripWelsh biotech Draig Therapeutics has come out of stealth backed by an impressive line-up of healthcare investors and led by a highly experienced leadership team as it bids to become a major player in
Pink SheetTrump Policies Draw Warnings From BIO Leadership US President Donald Trump was never directly called out by name, but BIO leadership discussed the risks posed by his policies on June 17 during the sec